GSDMA showed significant differences in mRNA expression between different clinical stages of four cancers, namely adrenocortical carcinoma (ACC), HNSC, testicular germ cell tumors (TGCT), and THCA (Figure 3B). This evidence concerns the gene GSDMA and adrenal cortex carcinoma.